subject: Psoriasis - Pipeline Assessment and Market Forecasts to 2017 [print this page] Psoriasis - Pipeline Assessment and Market Forecasts to 2017
Summary
GlobalData, the industry analysis specialist, has released its new report, "Psoriasis - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global psoriasis market. The report identifies the key trends shaping and driving the global psoriasis market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global psoriasis sector.
Psoriasis - Pipeline Assessment and Market Forecasts to 2017
Market Research
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
GlobalData estimates the global psoriasis therapeutics market to be valued at $2.7 billion in 2009. It is expected to grow with a Compound Annual Growth Rate (CAGR) of approximately 4.73% from $2.7 billion in 2009 to $3.9 billion by 2017. This growth is primarily attributed to increased competition among the existing products and also a strong pipeline with more emerging therapies. The current market is crowded with biologics and also topical treatments for psoriasis. The pipeline is also strong with biologics, as well as several other treatments for mild to moderate psoriasis. With the increased uptake of biologics and increased awareness of the disease in patients leading to increased treatment seeking rates in the early stages of the disease, the psoriasis therapeutics market is expected to generate large revenues
Scope
The report provides information on the key drivers and challenges of the psoriasis market. Its scope includes:
Annualized global psoriasis market revenues data from 2001 to 2009, forecast for eight years to 2017.
Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as TNF-alpha inhibitors, IL inhibitors contribute, corticosteroid, vitamin D, monoclonal antibodies, Growth Factor Beta 1 (TGF-B1) inhibitor peptides, Toll-like receptor (TLR) modulators, STAT pathway inhibitors, retinoic acid agents, Protein Kinase C (PKC) inhibitors, NF-kB inhibitors, naturally occurring proteins, Kv1.3 blockers, IL-22 modulators, IL-2 antagonists, cytokine modulators, antimetabolites, PDE-4 Inhibitors, JAK-3 Inhibitors and IL-23 antibodies.
Analysis of the current and future competition in the global psoriasis market. Key market players covered are Glaxao Smit Kline, Leo Pharma, Bristol-Myer Squibb, Novartis and Abott laboratories.
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the psoriasis therapeutics market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global psoriasis market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global psoriasis market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
What's the next big thing in the global psoriasis market landscape? Identify, understand and capitalize.
